VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by maintaining kidney function over a...
Search results for "T cells"
'Curb Appetite, Burn Fat': 8 Foods That Support Sustainable Weight Loss
Weight loss fundamentally relies on maintaining a caloric deficit—burning more energy than is consumed. Incorporating foods that lower overall...
Safe to Drink at Night: Six Bedtime Beverages That Help Manage Blood Sugar
What you drink before bed can shape not only your sleep quality but also your blood sugar levels the next day.
Quercetin Fights Inflammation: 3 Foods Packing More of the Antioxidant Than Onions
Free radicals are unstable molecules that drive internal inflammation, accelerate cellular aging, and heighten the risk...
Can You Take Too Many Supplements? Symptoms That Signal You Are Overdoing It
Supplements can be a convenient way to fill nutritional gaps, but consuming more than your body needs can harm your...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Antihistamines Provide Minimal Relief for Atopic Dermatitis Itch, Study Finds
Antihistamines commonly used to ease itching from atopic dermatitis do not deliver a large enough benefit for patients...
Could Your Breakfast Choice Accelerate Brain Aging? Foods to Avoid vs. Foods That Protect Cognitive Health
Breakfast is far more than a quick way to kickstart the day—it is a critical habit for safeguarding long-term brain...
Why Bones Break Before Osteoporosis Sets In: The Hidden Risk Behind Normal Scans
"I slipped and broke my wrist." "I fell, broke my hip, and even had to get surgery."Most people chalk these injuries up...
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...